These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 16249434)

  • 1. Aldose reductase deficiency prevents diabetes-induced blood-retinal barrier breakdown, apoptosis, and glial reactivation in the retina of db/db mice.
    Cheung AK; Fung MK; Lo AC; Lam TT; So KF; Chung SS; Chung SK
    Diabetes; 2005 Nov; 54(11):3119-25. PubMed ID: 16249434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More severe type 2 diabetes-associated ischemic stroke injury is alleviated in aldose reductase-deficient mice.
    Yeung CM; Lo AC; Cheung AK; Chung SS; Wong D; Chung SK
    J Neurosci Res; 2010 Jul; 88(9):2026-34. PubMed ID: 20143423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene deletion and pharmacological inhibition of aldose reductase protect against retinal ischemic injury.
    Cheung AK; Lo AC; So KF; Chung SS; Chung SK
    Exp Eye Res; 2007 Nov; 85(5):608-16. PubMed ID: 17727843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldose reductase deficiency reduced vascular changes in neonatal mouse retina in oxygen-induced retinopathy.
    Fu ZJ; Li SY; Kociok N; Wong D; Chung SK; Lo AC
    Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5698-712. PubMed ID: 22836764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldose reductase inhibition prevents endotoxin-induced inflammatory responses in retinal microglia.
    Chang KC; Ponder J; Labarbera DV; Petrash JM
    Invest Ophthalmol Vis Sci; 2014 May; 55(5):2853-61. PubMed ID: 24677107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electron microscopic immunocytochemical evidence for the mechanism of blood-retinal barrier breakdown in galactosemic rats and its association with aldose reductase expression and inhibition.
    Vinores SA; Van Niel E; Swerdloff JL; Campochiaro PA
    Exp Eye Res; 1993 Dec; 57(6):723-35. PubMed ID: 8150024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of aldose reductase from mice inhibits diabetes-induced retinal capillary degeneration and superoxide generation.
    Tang J; Du Y; Petrash JM; Sheibani N; Kern TS
    PLoS One; 2013; 8(4):e62081. PubMed ID: 23614016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
    Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y
    Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C1q/TNF-related protein-9 attenuates retinal inflammation and protects blood-retinal barrier in db/db mice.
    Li W; Ma N; Liu MX; Ye BJ; Li YJ; Hu HY; Tang YH
    Eur J Pharmacol; 2019 Jun; 853():289-298. PubMed ID: 30978318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas.
    Murata T; Nakagawa K; Khalil A; Ishibashi T; Inomata H; Sueishi K
    Lab Invest; 1996 Apr; 74(4):819-25. PubMed ID: 8606491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary Compound Chrysin Inhibits Retinal Neovascularization with Abnormal Capillaries in db/db Mice.
    Kang MK; Park SH; Kim YH; Lee EJ; Antika LD; Kim DY; Choi YJ; Kang YH
    Nutrients; 2016 Dec; 8(12):. PubMed ID: 27918469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products.
    Kaji Y; Usui T; Ishida S; Yamashiro K; Moore TC; Moore J; Yamamoto Y; Yamamoto H; Adamis AP
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):858-65. PubMed ID: 17251488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficiency of aldose reductase attenuates inner retinal neuronal changes in a mouse model of retinopathy of prematurity.
    Fu Z; Nian S; Li SY; Wong D; Chung SK; Lo AC
    Graefes Arch Clin Exp Ophthalmol; 2015 Sep; 253(9):1503-13. PubMed ID: 25921391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of advanced glycation and absence of galectin-3 prevent blood-retinal barrier dysfunction during short-term diabetes.
    Canning P; Glenn JV; Hsu DK; Liu FT; Gardiner TA; Stitt AW
    Exp Diabetes Res; 2007; 2007():51837. PubMed ID: 17641742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aldose reductase inhibitor fidarestat prevents retinal oxidative stress and vascular endothelial growth factor overexpression in streptozotocin-diabetic rats.
    Obrosova IG; Minchenko AG; Vasupuram R; White L; Abatan OI; Kumagai AK; Frank RN; Stevens MJ
    Diabetes; 2003 Mar; 52(3):864-71. PubMed ID: 12606532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF.
    Poulaki V; Qin W; Joussen AM; Hurlbut P; Wiegand SJ; Rudge J; Yancopoulos GD; Adamis AP
    J Clin Invest; 2002 Mar; 109(6):805-15. PubMed ID: 11901189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of Fas-FasL-induced endothelial cell apoptosis prevents diabetic blood-retinal barrier breakdown in a model of streptozotocin-induced diabetes.
    Joussen AM; Poulaki V; Mitsiades N; Cai WY; Suzuma I; Pak J; Ju ST; Rook SL; Esser P; Mitsiades CS; Kirchhof B; Adamis AP; Aiello LP
    FASEB J; 2003 Jan; 17(1):76-8. PubMed ID: 12475915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tonicity-responsive enhancer binding protein regulates the expression of aldose reductase and protein kinase C δ in a mouse model of diabetic retinopathy.
    Park J; Kim H; Park SY; Lim SW; Kim YS; Lee DH; Roh GS; Kim HJ; Kang SS; Cho GJ; Jeong BY; Kwon HM; Choi WS
    Exp Eye Res; 2014 May; 122():13-9. PubMed ID: 24631337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes.
    El-Remessy AB; Al-Shabrawey M; Khalifa Y; Tsai NT; Caldwell RB; Liou GI
    Am J Pathol; 2006 Jan; 168(1):235-44. PubMed ID: 16400026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of angiotensin II attenuates VEGF-mediated blood-retinal barrier breakdown in diabetic retinopathy.
    Kim JH; Kim JH; Yu YS; Cho CS; Kim KW
    J Cereb Blood Flow Metab; 2009 Mar; 29(3):621-8. PubMed ID: 19107135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.